PlainPharmaWatch

CMS Open Payments · Program Year 2024

Insulet Corporation

Insulet Corporation reported $7,202,281.81 across General Payments, Research, and Ownership to 17,948 physicians and teaching hospitals across 18,137 transactions.

See the rankings → How this is sourced
$7.2M
All-tracks total
18,137
Transactions
17,948
Recipients
+$1.8M
General Payments vs PY2023

Insulet Corporation reported $7,202,281.81 across all CMS Open Payments tracks (General + Research + Ownership) to 17,948 physicians and teaching hospitals in Program Year 2024 - ranking #218 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $3,862,461.10, averaging $401.29 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer insulet-corporation Insulet Corporation

$7.2M · #218/1,925 · 0.1% industry · PY2024

  • TOT $7.2M
  • RANK #218
  • SHARE 0.1%
  • TXN 18,137
  • RCP 17,948
  • CAT 6
  • GEN $3.9M
  • ΔGEN +$1.8M
  • TOP1 5.4%
  • PY 2024

Volume peers

Nearest volume peer: Solventum Corporation ($7.1M)

Skye Orthobiologics LLC$7.4MInsulet Corporation (this)$7.2MSolventum Corporation$7.1MNeurology Practice Consortiu…$7.0MWoven Orthopedic Technologie…$7.0M
All-tracks payment totals near Insulet Corporation (CMS Open Payments PY2024)

Insulet Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Insulet Corporation's CMS-reported General Payments increased by $1.8M (+86.5%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: INSULET CORPORATIONPY2023: INSULET CORPORATIONPY2024: Insulet Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$2.1MPY2024$3.9M
PY2023
$2,070,874.16
PY2024
$3,862,461.10

What the Data Shows for Insulet Corporation

Insulet Corporation ranks #218 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.1% slice of all industry payments reported nationwide for the year. The underlying total is $7,202,281.81 across 18,137 transactions to 17,948 physicians and teaching hospitals - $397.10 per transaction and $401.29 per recipient on average.

Of the 6 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $3.0M across 1,862 transactions, 76.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 6 types of general payments, Insulet Corporation's largest category was "Compensation for Services Other Than Consulting" at $3.0M - 76.6% of General Payments.

Insulet Corporation reports 6 general-payment categories - the top three are Compensation for Services Other Than Consulting (76.6%), Food and Beverage (10.5%), and Compensation for Faculty or Speaker (Medical Education) (10.2%). The remaining 3 categories make up 2.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Insulet Corporation divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$3.0M2. Food and Beverage$406.1K3. Compensation for Faculty …$393.2K4. Travel and Lodging$76.9K5. Space Rental or Facility …$21.7K6. Grant$6.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $3.0M 1,862
Food and Beverage $406.1K 15,070
Compensation for Faculty or Speaker (Medical Education) $393.2K 270
Travel and Lodging $76.9K 726
Space Rental or Facility Fees $21.7K 19
Grant $6.0K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $676,469.96 (17.5%) of $3,862,461.10 in this company's General Payments records across 5,953 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Insulet Corporation

The five named recipients with the highest reported General Payments from this company

Cleveland Clinic Hospital$210.0KAnita Narayan Swamy$131.3KChildrens Hospital Of The Ki…$116.5KParkview Hospital$110.1KDeaconess Medical Center$108.6K
  1. 1

    Cleveland Clinic Hospital

    $209,975.00 across 61 reported transactions

  2. 2

    Anita Narayan Swamy

    $131,344.96 across 198 reported transactions

  3. 3

    Childrens Hospital Of The Kings Da

    $116,475.00 across 24 reported transactions

  4. 4

    Parkview Hospital

    $110,100.00 across 29 reported transactions

  5. 5

    Deaconess Medical Center

    $108,575.00 across 30 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Insulet Corporation's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Insulet Corporation.

Alon Medical Technology

HHI 138

Johnson and Johnson International

HHI 138

KVK-Tech, Inc.

HHI 135

Genmab U.S., Inc.

HHI 135

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Insulet Corporation.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Insulet Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.